t(10;16)(q22;p13) and MORF ‐ CREBBP fusion is a recurrent event in acute myeloid leukemia
2003; Wiley; Volume: 36; Issue: 4 Linguagem: Inglês
10.1002/gcc.10174
ISSN1098-2264
AutoresJ.L. Vizmanos, María José Larráyoz, Idoya Lahortiga, Filomena Floristán, Carmen Álvarez-Domínguez, María D. Odero, Francisco J. Novo, Marı́a José Calasanz,
Tópico(s)Multiple Myeloma Research and Treatments
ResumoRecently, it was shown that t(10;16)(q22;p13) fuses the MORF and CREBBP genes in a case of childhood acute myeloid leukemia (AML) M5a, with a complex karyotype containing other rearrangements. Here, we report a new case with the MORF-CREBBP fusion in an 84-year-old patient diagnosed with AML M5b, in which the t(10;16)(q22;p13) was the only cytogenetic aberration. This supports that this is a recurrent pathogenic translocation in AML.
Referência(s)